Zustand: Very Good. 2002nd Edition. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 31,93
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. 440 Illus.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 86,57
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. pp. x + 189.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Couverture rigide. Zustand: bon. R160225216: 2002. In-8. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. XIV + 420 pages - ouvrage en anglais - nombreuses figures en noir et blanc dans le texte - tampon sur la page de garde et sur la page de titre. . . . Classification Dewey : 420-Langue anglaise. Anglo-saxon.
EUR 152,72
Anzahl: 1 verfügbar
In den WarenkorbZustand: Used. pp. 182.
Zustand: Used. pp. 182.
Verlag: Birkhäuser Basel, Birkhäuser Basel Dez 2007, 2007
ISBN 10: 3764386924 ISBN 13: 9783764386924
Sprache: Englisch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. Neuware -Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase).Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 204 pp. Englisch.
EUR 160,50
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 2nd revised edition. 189 pages. 9.25x6.50x0.75 inches. In Stock.
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase).Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.
Taschenbuch. Zustand: Neu. Hormone Therapy in Breast and Prostate Cancer | B. J. A. Furr (u. a.) | Taschenbuch | xiv | Englisch | 2009 | Humana | EAN 9781607614715 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Verlag: Humana Press, Humana Press Sep 2009, 2009
ISBN 10: 1607614715 ISBN 13: 9781607614715
Sprache: Englisch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. Neuware -In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying targeted hormonal treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 436 pp. Englisch.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 237,60
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. indexed edition. 420 pages. 9.00x6.25x1.25 inches. In Stock.